Metraipolis › archive › dc_290ebf5fb50d

Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel — Europe PMC PMID:38374060

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38374060
DOI
10.1186/s13584-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-10-08T01:32:43.616Z
SHA-256 of the archived text
6e480773f37f11f73a40aa28e88947733040c7adb6a768286fced81ee4f14f0f
Stable URL of this page
https://metraipolis.com/documento/dc_290ebf5fb50d

How to cite

Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel — Europe PMC PMID:38374060 — Europe PMC (en), https://europepmc.org/article/MED/38374060 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_290ebf5fb50d (Metraipolis archive dc_290ebf5fb50d, sha256 6e480773f37f11f73a40aa28e88947733040c7adb6a768286fced81ee4f14f0f)
BibTeX
@misc{dc290ebf5fb50d,
  title = {Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel — Europe PMC PMID:38374060},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38374060},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_290ebf5fb50d; sha256 6e480773f37f11f73a40aa28e88947733040c7adb6a768286fced81ee4f14f0f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38374060. Agents can read the archived copy with the MCP tool read_document.